@article{0f38f0ebf3b24a139e92b520271e9c60,
title = "Employing PEG crosslinkers to optimize cell viability in gel phase bioinks and tailor post printing mechanical properties",
abstract = "The field of 3D bioprinting has rapidly grown, yet the fundamental ability to manipulate material properties has been challenging with current bioink methods. Here, we change bioink properties using our PEG cross-linking (PEGX) bioink method with the objective of optimizing cell viability while retaining control of mechanical properties of the final bioprinted construct. First, we investigate cytocompatible, covalent cross-linking chemistries for bioink synthesis (e.g. Thiol Michael type addition and bioorthogonal inverse electron demand Diels-Alder reaction). We demonstrate these reactions are compatible with the bioink method, which results in high cell viability. The PEGX method is then exploited to optimize extruded cell viability by manipulating bioink gel robustness, characterized by mass flow rate. Below a critical point, cell viability linearly decreases with decreasing flow rates, but above this point, high viability is achieved. This work underscores the importance of building a foundational understanding of the relationships between extrudable bioink properties and cell health post-printing to more efficiently tune material properties for a variety of tissue and organ engineering applications. Finally, we also develop a post-printing, cell-friendly cross-linking strategy utilizing the same reactions used for synthesis. This secondary cross-linking leads to a range of mechanical properties relevant to soft tissue engineering as well as highly viable cell-laden gels stable for over one month in culture. Statement of Significance: We demonstrate that a PEG crosslinking bioink method can be used with various cytocompatible, covalent cross-linking reactions: Thiol Michael type addition and tetrazine-norbornene click. The ability to vary bioink chemistry expands candidate polymers, and therefore can expedite development of new bioinks from unique polymers. We confirm post-printed cell viability and are the first to probe, in covalently cross-linked inks, how cell viability is impacted by different flow properties (mass flow rate). Finally, we also present PEG cross-linking as a new method of post-printing cross-linking that improves mechanical properties and stability while maintaining cell viability. By varying the cross-linking reaction, this method can be applicable to many types of polymers/inks for easy adoption by others investigating bioinks and hydrogels.",
keywords = "Bioorthogonal, Bioprinting, Cytocompatability, Hydrogel, Tissue engineering",
author = "Rutz, {Alexandra L.} and Gargus, {Emma S.} and Hyland, {Kelly E.} and Lewis, {Phillip L.} and Aakash Setty and Burghardt, {Wesley R.} and Shah, {Ramille N.}",
note = "Funding Information: The authors thank Dr. Joshua Z. Rappoport and Dr. Constadina Arvanitis of the Center of Advanced Microscopy as well as Dr. Matthew J. Gastinger of Bitplane Inc. for assistance with confocal microscopy and image analysis. Imaging work was performed at the Northwestern University Center for Advanced Microscopy generously supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center. Authors also acknowledge use of the Equipment Core Facilities at the Simpson Querrey Institute for BioNanotechnology at Northwestern University developed by support from The U.S. Army Research Office, the U.S. Army Medical Research and Materiel Command, and Northwestern University. This work made use of the rheometer in the MatCI Facility, which receives support from the MRSEC Program (NSF DMR-1121262) of the Materials Research Center at Northwestern University. This work was supported by the National Institutes of Health (1K01DK099454-01) and National Science Foundation, United States (Graduate Research Fellowship for A.L. Rutz, DGE-1324585). R.N.S. is a co-founder and shareholder in Dimension Inx, LLC which designs, develops, manufactures, and sells new 3D-printable materials and end use products for medical and non-medical applications. RNS is the Chief Science Officer of Dimension Inx, LLC. Funding Information: The authors thank Dr. Joshua Z. Rappoport and Dr. Constadina Arvanitis of the Center of Advanced Microscopy as well as Dr. Matthew J. Gastinger of Bitplane Inc. for assistance with confocal microscopy and image analysis. Imaging work was performed at the Northwestern University Center for Advanced Microscopy generously supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center. Authors also acknowledge use of the Equipment Core Facilities at the Simpson Querrey Institute for BioNanotechnology at Northwestern University developed by support from The U.S. Army Research Office, the U.S. Army Medical Research and Materiel Command, and Northwestern University. This work made use of the rheometer in the MatCI Facility, which receives support from the MRSEC Program (NSF DMR-1121262) of the Materials Research Center at Northwestern University. This work was supported by the National Institutes of Health ( 1K01DK099454-01 ) and National Science Foundation , United States (Graduate Research Fellowship for A.L. Rutz, DGE-1324585 ). Publisher Copyright: {\textcopyright} 2019",
year = "2019",
month = nov,
doi = "10.1016/j.actbio.2019.09.007",
language = "English (US)",
volume = "99",
pages = "121--132",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "Elsevier BV",
}